**Meet the editor**

Professor Farid Badria received his PhD degree in Pharmacognosy (Microbial Transformation) from the University of Mississippi, USA, with a BSc degree in Pharmaceutical Sciences and two masters degrees of Science in Pharmacognosy and Cell Biology from Mansoura University and the University of Minnesota.TWAS-ARO (The World Academy of Sciences for the advancement of

science in developing countries, Arab Regional Office, 2013) award; World Intellectual Property Organization Gold Medal, 2011 [the best inventor in Egypt]; State Recognition Outstanding Award in Medicine (Egyptian Academy of Science) 2001; Outstanding Arab Scholar, Kuwait (2000); and Khwarizmi International Award, Iran (2000), to mention a few, are just some of the awards he received.

He has also been a scholar of the Arab Development Fund, Kuwait (2000); ICRO-UNESCO International, Chile (1999); UNESCO Biotechnology Fellowship, France (1994); and Honorary Fellowship, University of Mississippi, USA (1987–1990).

Prof. Badria has submitted 44 patents to the Egyptian Academy of Sciences, of which 16 had been granted final certificates with intellectual protection for 20 years. With over 170 publications, 10 books, and other international contributions, he continues to lead research projects on developing new therapy for liver disorders, parasites, malnutrition, simple diagnostic tools, arthritis, skin disorders, and biomarkers for cancer.

## Contents

**Preface XI**


Chapter 5 **Lycopene: Multitargeted Applications in Cancer Therapy 79** Kazim Sahin, Shakir Ali, Nurhan Sahin, Cemal Orhan and Omer Kucuk

### **Section 3 Anticancer Compounds from Cannabinoids and Endophytic Fungi 109**


Danciu Corina, Soica Codruta, Antal Diana, Alexandra Popescu, Roxana Ghiulai, Ioana Zinuca Pavel, Stefana Avram, Minda Daliana and Cristina Dehelean

